An aggressive RhoC phenotype is associated with relapse after external beam radiation therapy of a prostate cancer xenograft model.

e14748Background: Relapsed treatment resistant prostate cancer remains the second most common cause of male mortality in the western world. New therapies for therapy resistant prostate cancer depen...